industry
Medical Cannabis Costs Fall 20% in Two Years as Market Matures
Average monthly medicine costs for UK medical cannabis patients have fallen by approximately 20% over the past two years as competition between clinics and.
Increasing competition in the UK medical cannabis sector is translating into meaningful cost reductions for patients. Analysis of pricing data from LeafMe and the Cannabis Industry Council shows that average monthly medicine costs have declined from approximately £250 in 2022 to around £200 in 2024, with further reductions expected as more generic products enter the market.
More Industry News
Industry
Aurora Cannabis Reports Record UK Patient Numbers
Aurora Cannabis has reported a record number of active patients in the United Kingdom, surpassing 15,000 registered ind…
24 May 2026
Industry
Pharmacies Across UK Begin Stocking Medical Cannabis Products
A growing number of community pharmacies across the United Kingdom have begun stocking licensed medical cannabis produc…
22 May 2026
Industry
Tilray Brands Launches New High-CBD Product for UK Market
Tilray Brands has announced the UK launch of a new high-CBD, low-THC medical cannabis flower product targeting anxiety …
20 May 2026
More News
product
Adven EMT-3: UK Availability, Price and Prescribing Guide
07 Jun 2026
product
Bedrolite CBD Oil UK: Prices, Availability and Patient Guide
07 Jun 2026
news
Alternaleaf UK: Full Product List, Prices and Patient Review 2026
07 Jun 2026
regulation
Bedrocan Expands UK Distribution Network
26 May 2026